Jentadueto

Jentadueto, a medication used to treat type 2 diabetes containing linagliptin and metformin hydrochloride, is being recalled across the European Union due to a quality defect. The recall is classified as Class I, which is the most serious classification. This recall affects all patients in the EU who have been prescribed this medication.

Product

Active substances: linagliptin;metformin hydrochloride. Therapeutic area: Diabetes Mellitus, Type 2. ATC code: A10BD11

Reason

Quality defect

Classification

Class I

Category

drug recall

Country

European Union

Agency

EMA-DHPC

Recall date

2026-08-20

Status

Ongoing

Distribution

European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/e79d93eb-a893-4037-a2c5-9bee9b06e3c2